Clareo Health | PET/MRI Study of Men With Highly Suspicious MRI Lesions That Showed no Clinically Significant Prostate Cancer Following MRI Fusion Targeted Biopsy
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NYU Langone Health
Age
18–100
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
The participant has undergone MRFTB of an MRI lesion at the Department of Urology or at NYU Langone Health within past 12 months and has signed informed consent to participate in the NYU Urology prostate biopsy database.
The most recent MRFTB of a PIRADS 4 or 5 lesion did not show clinically significant prostate cancer.
You may not be if
The urologist who performed the initial MRFTB does not feel a repeat MRI is indicated.
Any contraindication to prostate biopsy including untreated urinary tract infection
